Psychedelic-assisted therapy refers to the therapeutic use of psychedelic drugs such as LSD, psilocybin, DMT, mescaline, and MDMA under strict professional supervision. Clients are prepared in advance by the therapist and then helped afterward to integrate and understand their experience with the drug. In a psychedelic-assisted therapy session, the client is administered the drug and then, as the drug takes effect, guided by the therapist to explore their feelings and experience. Both client and therapist remain in session until the drug wears off completely. Follow-up sessions help the client fully integrate their experiences.
In an appropriate context, ayahuasca can be a valuable therapeutic tool and can act as a catalyst that can render psychotherapeutic processes more effective in less time, and sometimes allow for critical interventions when several other therapeutic strategies have been unsuccessful.
Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.
When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction, and anxiety, he did not intend to write what is undoubtedly his most...
Research over the last decade has shown MDMA-assisted psychotherapy to be effective in treating PTSD from military combat, sexual assault and childhood abuse. Now researchers are trialing MDMA with couples and finding promising results.
A comprehensive guide to the safe and ethical application of expanded states of consciousness for therapists, healing practitioners, and sincere explorers. Psychedelic medicines also known as entheogens are entering the mainstream.